Announcements Trials
Browse Landscape

Phase

Phase NA 35Phase 2 17Phase 3 4Phase 1/2 3Phase 1 3Phase 4 2Phase 2/3 2

Status

Completed 2Unknown 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 1Endocrine 1

Conditions

Colorectal Neoplasms 1Adrenal Gland Neoplasms 1

Interventions

Cisplatin 22Fluorouracil 21Radiotherapy 18Gemcitabine 17Docetaxel 16Oxaliplatin 15Paclitaxel 14Carboplatin 13Capecitabine 13Bevacizumab 13Leucovorin 11Cyclophosphamide 11Irinotecan 10Drug Therapy 10Cytarabine 9Saline Solution 7Magnetic Resonance Spectroscopy 7Letrozole 7Dexamethasone 7Rituximab 6Nivolumab 6Methotrexate 6Exercise 6Etoposide 6Electroporation 6Doxorubicin 6pembrolizumab 5Pemetrexed 5Metformin 5Melphalan 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2/3 × Completed × Radiofrequency Ablation × Clear all
NCT00997594 2015-04-28

Changes in Adrenal Hormones During Adrenal Radiofrequency Ablation

Mie University

Phase 2/3 Completed
18 enrolled 6 charts
Endocrine

Adrenal Gland Neoplasms

NCT02419677 2015-04-17

Radiofrquency Ablation Combined With Cytokine-induced Killer Cells for Colorectal Cancer Liver Metastases

The First People's Hospital of Changzhou

Phase 2/3 Completed
60 enrolled
Gastrointestinal

Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡